Afuco™ Anti-Human ACVR2B ADCC Therapeutic Antibody (ANB012), ADCC Enhanced
Anti-ACVR2B ADCC Enhanced Antibody (ANB012) is an ADCC enhanced antibody produced by our Afuco™ platform. ANB012 is a pre-clinical antibody that antagonizes ActRIIB. ActRIIB antagonism has been shown to downregulate a variety of factors that lead to muscle loss and wasting.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-011CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ACVR2B |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |